Scholarlink

Purpose <p>Following the initial reports demonstrating the feasibility of immunoPET imaging of simian immunodeficiency virus (SIV) using gp120-targeting monoclonal antibodies in non-human primates, replication efforts of the imaging system in human immunodeficiency virus (HIV)-infected individuals have yielded conflicting results. Herein, we used two anti-gp120 antibodies, 7D3 and ITS103.01LS-F(ab’)<sub>2</sub>, to interrogate the reproducibility of gp120-targeting probes for immunoPET imaging of SIV in rhesus macaques.</p> Methods <p>The binding affinity estimates of <sup>89</sup>Zr radiolabeled 7D3 and ITS103.01LS-F(ab’)<sub>2</sub> to SIV gp120, and the in-vitro and ex-vivo binding specificities of [<sup>89</sup>Zr]Zr-7D3 and [<sup>89</sup>Zr]Zr-ITS103.01LS-F(ab’)<sub>2</sub> to SIV Env expressing cells, primary cells, and tissue sections from uninfected and SIV-infected macaques were obtained through competition assays. The biodistributions of [<sup>89</sup>Zr]Zr-7D3 and [<sup>89</sup>Zr]Zr-ITS103.01LS-F(ab’)<sub>2</sub> were performed with static PET scans up to 6 days post-injection in 20 rhesus macaques and the standardized uptake values in various tissues were compared between SIV-infected and uninfected controls.</p> Results <p>Despite the demonstrated nanomolar affinity of [<sup>89</sup>Zr]Zr-7D3 and [<sup>89</sup>Zr]Zr-ITS103.01LS-F(ab’)<sub>2</sub> to SIV gp120, and strong binding specificity to SIV gp120 cell lines, we observed no discernible differences in their binding in primary cells, tissue sections of secondary lymphoid organs, in-vivo probe uptake between SIV-infected and uninfected macaques, or ex-vivo validation necropsies. While the probes remained stable in-vivo, only [<sup>89</sup>Zr]Zr-ITS103.01LS-F(ab’)<sub>2</sub> in chronic plasma retained its binding specificity to SIV gp120, with [<sup>89</sup>Zr]Zr-7D3 experiencing a &gt; 97% reduction in binding to gp120 due to competition from endogenous antibodies at the 7D3 binding site.</p> Conclusion <p>The overall absence of specific uptake suggests inadequate binding potential (ligand affinity x target molarity) for these probes to effectively image SIV or HIV in-vivo, warranting further investigation into the lack of reproducibility observed with earlier non-human primate SIV imaging and conflicting human studies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Whole-body PET imaging of simian immunodeficiency virus using gp120-targeting probes fails to reveal regions of specific uptake in rhesus macaques

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月31日

查看全文
  • Sharat Srinivasula,
  • Insook Kim,
  • Hyukjin Jang,
  • Paula Degrange,
  • Heather Brown,
  • Viviana Dalton,
  • Yunden Badralmaa,
  • Ven Natarajan,
  • Brad Long,
  • Jorge A. Carrasquillo,
  • Michele Di Mascio

摘要

Purpose

Following the initial reports demonstrating the feasibility of immunoPET imaging of simian immunodeficiency virus (SIV) using gp120-targeting monoclonal antibodies in non-human primates, replication efforts of the imaging system in human immunodeficiency virus (HIV)-infected individuals have yielded conflicting results. Herein, we used two anti-gp120 antibodies, 7D3 and ITS103.01LS-F(ab’)2, to interrogate the reproducibility of gp120-targeting probes for immunoPET imaging of SIV in rhesus macaques.

Methods

The binding affinity estimates of 89Zr radiolabeled 7D3 and ITS103.01LS-F(ab’)2 to SIV gp120, and the in-vitro and ex-vivo binding specificities of [89Zr]Zr-7D3 and [89Zr]Zr-ITS103.01LS-F(ab’)2 to SIV Env expressing cells, primary cells, and tissue sections from uninfected and SIV-infected macaques were obtained through competition assays. The biodistributions of [89Zr]Zr-7D3 and [89Zr]Zr-ITS103.01LS-F(ab’)2 were performed with static PET scans up to 6 days post-injection in 20 rhesus macaques and the standardized uptake values in various tissues were compared between SIV-infected and uninfected controls.

Results

Despite the demonstrated nanomolar affinity of [89Zr]Zr-7D3 and [89Zr]Zr-ITS103.01LS-F(ab’)2 to SIV gp120, and strong binding specificity to SIV gp120 cell lines, we observed no discernible differences in their binding in primary cells, tissue sections of secondary lymphoid organs, in-vivo probe uptake between SIV-infected and uninfected macaques, or ex-vivo validation necropsies. While the probes remained stable in-vivo, only [89Zr]Zr-ITS103.01LS-F(ab’)2 in chronic plasma retained its binding specificity to SIV gp120, with [89Zr]Zr-7D3 experiencing a > 97% reduction in binding to gp120 due to competition from endogenous antibodies at the 7D3 binding site.

Conclusion

The overall absence of specific uptake suggests inadequate binding potential (ligand affinity x target molarity) for these probes to effectively image SIV or HIV in-vivo, warranting further investigation into the lack of reproducibility observed with earlier non-human primate SIV imaging and conflicting human studies.